AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Most Read
1. Singapore startups pivot to deep tech as funding tightens 2. Hong Kong insurance C-Suite pay hits $3m as affluent client focus drives 2026 hiring 3. Charging and cost hurdles temper Singapore’s EV momentum 4. Finance hiring gains momentum across key banking segments, report says 5. Ransomware groups surge as July attacks hit SingaporeResource Center
Read Here
Advertise
Sign Up
Awards
Event News
Asian Management Excellence Awards 2026 Winner: Dr Toungtam Srilajaroan of Zoetis Thailand Limited
Dr Toungtam Srilajaroan of Zoetis Thailand Limited emphasises how the company balances rapid responsiveness with strategic commitment.
Commentary
The survival playbook for the CEO amidst geopolitical conflicts